Full Transcript Introduction: Why Trust in Science Has Eroded 0:00 For nearly two decades, Alzheimer's research has been dominated by what's called the amyloid hypothesis. 0:07 The idea that the buildup of amlyloids beta protein plaques in the brain is the primary driver of the disease. 0:14 Working alongside top protein tangles, which are the other major hallmark researchers look at. 0:20 Welcome to Health Breakthroughs with Dr. 0:21 Stengler. 0:22 I'm Dr Mark Stegler and each episode we cut through the noise to bring you practical, science-backed insights for more energy, 0:29 better health and a life that feels like yours again. 0:35 Hey everybody, great to be with you. 0:37 If your trust in science and medicine has taken a real hit over the last few years, you're not alone. 0:42 Survey after survey shows that public confidence in scientific institutions has dropped dramatically, especially since COVID. 0:49 And honestly, as someone who's spent my entire career in healthcare, I think a lot of that skepticism has been earned. 0:56 So today I want to walk you through some of the real reasons behind the lack of confidence in science because of what people have experienced. 1:04 Going through documented cases of fraud, manipulation, conflicts of interest, and other reasons why the most respected journals in the world have become suspect. 1:13 We're going to look at how common fraud actually is in medical research, a landmark Alzheimer's case that may have shaped two decades of research funding, 1:21 some of the most infamous COVID-era attractions, the role pharmaceutical money plays in what gets published, and take a deep dive into one of most prescribed 1:31 classes of drugs in the world, antidepressants. 1:33 Also, I'm going review a controversial 2025 genetics paper. 1:37 what the data really shows about how we're so different from other supposed ancestors. 1:44 And also look at some scary vitamin and cancer headlines that fell apart once you look deep at the fine print like I've done. 1:52 My goal isn't to make you throw out science altogether, but to help you become more informed, more critical of it. 1:59 You've done everything you were told to do and something still feels off. 2:03 Health Breakthroughs with Dr. 2:04 Stengler, we go beyond symptom management to explore integrative, science-backed approaches to the issues that medicine too often overlooks.
Retractions, Fraud, and Paper Mills in Research 2:12 Chronic fatigue, brain fog, gut dysfunction, inflammation, hormone imbalance, and healthy aging. 2:17 If you're ready for real answers and practical tools to support your health naturally, follow Health breakthroughs of Dr Stegler on Doctor Talks or wherever 2:26 you listen to podcasts. 2:28 Let's start with the numbers, because they're honestly staggering. 2:31 In 2023, more than 10,000 scientific papers were retracted worldwide. 2:37 According to the publication Nature, a new annual record and more the total number retract in the three years from 2020 to 2022 combined. 2:48 For example, in 2024, another 9,000 plus retractions followed, and 2025 was on pace for thousands more. 2:56 Researchers who study this, including the team behind the Retraction Watch database, say this is just a tip of the iceberg because most fraudulent papers 3:05 are never caught at all. 3:07 And the reasons behind these retraction are telling. 3:09 A large share are linked to what are called paper mills. 3:12 businesses that sell fake research, fabricated data, and even authorship slots to researchers who need publications for career advancement. 3:22 Thousands more retractions have been tied to compromised peer review, where reviewers and editors essentially rig the system. 3:30 An older analysis of more than 2,000 retracted biomedical papers found that 43% were due to fraud or suspected fraud, with research misconduct as a share 3:41 of all retractions increasing roughly tenfold since the 1970s. 3:46 So when people say trust of science, it's worth remembering that science is a human institution. 3:52 Really, some methodology used by humans. 3:54 And like any human institutions, It has a real and growing fraud problem. 3:59 One that even the people running these databases openly call alarming. 4:03 So let's talk about the pharmaceutical industry's influence on research. 4:08 Now this is something that doesn't always involve outright fraud, but is arguably even more pervasive, that is the influence of pharmaceutical companies 4:18 funding on what gets studied, what is published, and how results get framed. 4:23 A major Cochrane review, one of the gold standards for evidence synthesis, pulled data from more than 8,000 clinical trials and found that industry-funded 4:32 studies were about 27% more likely to report favorable efficacy results and about 34% percent more like to reach favorable overall conclusions compared 4:43 to independently funded research. 4:46 And here's the interesting part. 4:47 This wasn't because the industry-funded trials had worse methodology. 4:51 In fact, on paper, they often looked just as rigorous, sometimes even better designed in terms of blinding. 4:59 The researchers concluded that there is a bias here that simply can't be explained by standard quality checks. 5:06 Funding source itself appears to shape outcomes. 5:09 A more recent study took this even further by comparing trials where the exact same two drugs were tested against each other, 5:16 with the only difference being who paid for the study.
Pharmaceutical Funding and Publication Bias 5:19 The example researchers point to is the antidepressant Effexor versus Prozac. 5:24 When EffExor's manufacturer funded the trial, EffXor came out looking better in 12 out of 14 studies. 5:30 But in the handful of trials funded by other sources, that pattern flipped. 5:35 Only one out three found EffExor superior. 5:38 Same drugs, same comparisons. 5:40 widely different results depending on who was footing the bill. 5:43 And this goes beyond just funding outcomes. 5:46 Investigations have documented how pharmaceutical companies sometimes use ghost writers for studies that are then signed by academic researchers, 5:54 how unfavorable trial results often simply never get published at all, and how companies have, in some documented cases, 6:02 actively tried to block publication of studies, that made their products look bad. 6:06 One review of the New England Journal of Medicine found that out of 73 new drug studies, a pharmaceutical company funded 60 of them, 6:14 half had drug company employees as co-authors, and the majority of lead researchers had taken money from a drug companies. 6:21 That's not necessarily proof of wrongdoing in any individual case, but it paints a picture of just how intertwined industry money is with the research 6:31 that ends up shaping clinical guidelines and ultimately what your doctor recommends to you. 6:36 Now let's get into a specific case that I think illustrates just how much damage one fraudulent paper can do. 6:42 And this one is connected to Alzheimer's disease, one of the most devastating and costly conditions in modern medicine. 6:49 For nearly two decades, Alzheimer's research has been dominated by what's called the amyloid hypothesis. 6:56 The idea that the buildup of amlyloids beta protein plaques in the brain is the primary driver of the disease. 7:03 Working alongside top protein tangles, which are the other major hallmark researchers look at. 7:10 In 2006, a study published in the prestigious journal Nature, led by neuroscientist Lesney, claimed to identify a specific amyloid beta protein assembly 7:21 as a direct cause of memory loss in mice. 7:23 This paper became one of the most cited Alzheimer's studies in history. 7:28 cited in roughly 2,300 other papers, and it helped funnel hundreds of millions of dollars in NIH funding towards amyloid-focused research every single year. 7:39 Then in 2022, a science magazine investigation, prompted by a whistle-blowing neuroscientist named Matthew Schrag, found evidence that key images in that 2006 7:51 paper called Western Blots appeared to have been digitally manipulated to better support the hypothesis. 7:58 Once investigators started looking closer, they found similar red flags across more than 20 of Lesnay's other papers. 8:04 In 2024, the original 2006 paper was formally retracted, becoming the second most highly cited paper ever retract in scientific history. 8:14 Now, to be fair, most researchers in the field say this one paper didn't single-handedly create the amyloid hypothesis. 8:21 There are many other studies pointing that direction too, but here's the part that should concern all of us. 8:27 For nearly 18 years, failures to replicate this work were largely ignored.
The Alzheimer's Amyloid Hypothesis and the Lesnu00e9 Retraction 8:32 The lead researcher kept receiving multi-million dollar grants and an enormous share of Alzheimer's drug development, drugs that ultimately failed in clinical trials. 8:42 This was built on a foundation that included fabricated data. 8:46 Meanwhile, alternative angles, including top-focused approaches, vascular contributions, neuroinflammation, arguably didn't get the attention or funding 8:56 they deserve. 8:57 This is a case where fraud didn't just embarrass one scientist, it may have shaped the direction on an entire field of medicine and the patients waiting 9:05 for treatments for two decades. 9:07 Now let's move to the COVID-19 fiasco because this is where a lot of people's trust really started to crack. 9:14 And that includes not just the population, but also many doctors and researchers. 9:19 There are so many things that one could talk about from the misleading statement that those vaccinated would not spread the disease to the six feet distancing 9:28 to promoting vaccination to healthy children without any research. 9:32 And let's talk about published data known as the Surgeosphere scandal. 9:36 In May 2020, in the early chaotic months of COVID-19, two papers were published using data from a company called Surgesphere. 9:44 One in The Lancet and one in New England Journal of Medicine. 9:47 Two of the most prestigious medical journals on the planet. 9:51 The Lancet paper claimed that hydroxychloroquine, a drug that had become politically and publicly controversial, significantly increased the risk of death 10:00 in COVID-19 patients. 10:02 The single paper was so influential that the World Health Organization temporarily halted global clinical trials of the drug. 10:10 But almost immediately, independent scientists started raising red flags. 10:14 The numbers in Surgesphere's supposed database of tens of thousands of patients across hundreds of hospitals worldwide didn't add up. 10:23 Some of the reported patient counts exceeded the actual number of COVID cases in those countries at the time. 10:29 When the reviewers were asked to audit the raw data, Surgeon Sphere refused to hand it over. 10:34 Within about two weeks, both papers were retracted, and the World Health Organization resumed its trials. 10:41 The retraction notice itself admitted the authors could no longer, quote, vouch for the racity of their primary data sources, 10:49 unquote. 10:49 Here's the kicker, though. 10:51 Even after the retraction, researchers found that one of these papers was still being cited by other scientific articles hundreds of times afterward. 11:00 Because retractions don't always catch up with how fast bad information spreads, especially once it's shaped public health policy, 11:08 and media coverage. 11:09 This episode showed millions of people in real time just how fast unverified data could move from a sketchy company into two of the most trusted journals 11:17 in the world and into the World Health Organization decision all in a matter of weeks. 11:24 Let's bring this conversation closer to home because this next example touches millions directly anti-depressants. 11:31 One of the most influential investigations here came from psychologist Irving Kirsch and his colleagues. 11:37 Their 2008 study titled Initial Severity in Antidepressant Benefits, a meta-analysis of data submitted to the Food and Drug Administration. 11:46 and this was published in the journal PLOS Medicine. 11:50 Instead of looking only at studies that appeared in medical journals, Kirsch's team obtained both the published and unpublished antidepressant trials that 11:59 pharmaceutical companies had submitted to the FDA for approval. 12:02 The results shocked a lot of people. 12:04 Kirshner's team found that roughly 82% of improvement seen in patients taking antidepressants was also seen patients in taking a placebo, 12:14 which of course are pills with no active medication at all.
COVID-Era Journal Scandals and the Surgisphere Case 12:19 The average difference between antidespressant and placebo was still statistically significant, but much smaller than many doctors and patients had been 12:28 led to believe. 12:29 Even more striking for people with mild to moderate depression, that benefit often failed to reach the threshold the United Kingdom's National Institute 12:38 for Health and Care Excellence uses to define a clinically meaningful improvement. 12:44 It was really only among people of very severe depression that antidepressants showed a more substantial advantage over a placebo. 12:52 Then another landmark study raised even more questions. 12:55 That same year, Eric Turner and his colleagues published a paper called Selective Publication of Anti-Depressant Trials and Its Influence on Apparent Efficacy 13:04 in the New England Journal of Medicine. 13:06 They compared the anti-depressants trials that had been submitted to the FDA with the studies that eventually appeared in medical journals, 13:13 and the pattern was striking. 13:14 Nearly all of the positive trials were published, while many of negative studies either remained unpublished or were written up in ways that made the results 13:24 look positive. 13:26 As a result, Turner's team concluded that the medical literature had exaggerated the apparent effectiveness of antidepressants by roughly 32%. Hey everybody, 13:36 I want to take just a quick moment and invite you to my website drstengler.com. 13:41 Here we have the supplements that we've been using with our patients for many, many years. 13:45 High quality and high potency supplements, very pure. 13:49 So, if you're looking for high quality supplements where you can notice a difference, both in how you feel and on your lab tests, 13:55 go to our website at dr.stegler dot com. 13:59 At this point, some people understandably conclude that anti-depressants didn't work at all. 14:04 But the story doesn't end there. 14:06 A decade later, in 2018, Andrea Cipriani and a large international team published a paper called Comparative Efficacy and Acceptability of 21 Anti-Depressant 14:18 Drugs for the Acute Treatment of Adults with Major Depressive Disorder in the Lancet. 14:22 one of the largest analyses ever performed on this topic, pulling together 522 clinical trials involving more than 116,000 patients. 14:32 Their conclusion was that every single antidepressant studied performed better than placebo, but the differences were generally modest rather than dramatic, 14:41 and a large share of patients still didn't respond to treatment at all. 14:44 So where does that leave us? 14:47 Not at antidepressants are sham and not at anti-depressants or miracle drugs either. 14:52 The honest evidence-based middle ground is something closer to this. 14:56 These medications do on average outperform placebo, especially for more severe depression.
Antidepressants: Published vs. FDA Trial Data 15:02 But for a lot of people with milder symptoms, the real world benefit appears to be smaller than decades of marketing and even well-meaning clinical guidance 15:11 that's been suggested. 15:13 And notice what it took to get an accurate picture here. 15:16 It wasn't a retraction. 15:17 it wasn' t a whistleblower exposing fabricated images. 15:21 t was independent researchers going around the published literature entirely employing the raw trial data straight from the FDA. 15:30 Once again, the full picture only emerged once people went looking at the data that never made it into a journal in the first place. 15:37 Now I want to bring up a more recent example and it involves genetics because I think it highlights how the most important numbers in a major scientific 15:46 paper can end up being tucked away where almost nobody will read them. 15:50 In May 2025, Nature published a paper called Complete Sequency of Ape Genomes. 15:57 Now, for decades, the figure most of us have heard is that humans and chimpanzees share about 99% of their DNA, sometimes phrased as only 1% different. 16:09 That statistic has been repeated in textbooks, museum exhibits, and documentaries for years. 16:15 The new paper, however, used complete, gap-free, end-to-end genome sequences for the first time. 16:22 And the results tell a very different story. 16:24 But you have to go looking for them. 16:26 The main 17 page article does not state a simple overall percent difference figure between humans and chimpanzees. 16:33 Instead, that number is buried inside a separate 173 page supplementary information document and tables numbered 3.19 and 3 .20. When you pull those numbers 16:47 out here's what they show. 16:48 For the autosomes, that is the regular non-sex chromosomes, the gaps alone, meaning stretches of DNA that don't even line up between the two species, 16:56 accounts for somewhere between 12.5 and 13.3 percent difference. 17:03 When you add in the single letter differences within the parts that do line up, the total divergence between the human and chimpanzee autosomes comes out 17:12 somewhere between 14 and 15%. That's roughly 14 to 15 times higher than the famous 1% figure. 17:19 In addition, if you look at the Y chromosome, the similarity was only 12.4%, so a major difference. 17:27 So you have a 2025 paper published in one of the most prestigious journals on the planet, reporting that humans and chimpanzees are roughly 14 to 15% different 17:37 across the autosomes, and even more different on sex chromosomes by high magnitudes. 17:42 And that headline number doesn't appear anywhere in the main text in that main paper. 17:47 For a finding of this magnitude on a statistic that has been quoted in classrooms and documentaries for 40 years, it's reasonable to ask why the actual 17:56 comparison wasn't placed front and center in the paper itself, rather than requiring readers to dig through more than 100 pages of supplementary tables
Genetics Claims and the Human-Chimpanzee DNA Gap 18:04 to find it. 18:05 So at one point, you may have heard that vitamin E causes cancer, or that beta carotene, the supplement, increases lung cancer risk. 18:13 But here's the twist, and the details matter a lot. 18:16 Take the SELECT trial, a massive study with over 35,000 men, published in JAMA back in 2011. It found that men taking 400 IUs of vitamin E every day had 18:27 about a 17% higher risk of developing prostate cancer compared to men on placebo. 18:32 Sounds alarming, right? 18:34 But here's the catch. 18:35 The vitamin used in that study was a synthetic lab-made version called DL-alpha-ticarferol. 18:41 The DL is the giveaway. 18:43 It means the supplement was actually a mix of eight different molecular versions and only one of those eight is to form your body actually recognizes as 18:51 natural vitamin E. 18:52 In other words, it's not in the foods you eat and it is actually not even the type you find in vast vast majority of supplements. 19:00 So when headlines say that vitamin E causes cancer, what they're really describing is one specific synthetic form, giving it high doses to a general population 19:08 and not anywhere near what you'd find in the structure of natural vitamin D most people are using as a supplement. 19:15 A similar story plays out with beta-carotene. 19:18 Two major trials, the ATBC study and the CARET study, both published in the New England Journal of Medicine in 1990s, found that high dose beta caroten 19:30 supplements actually increased lung cancer rates. 19:32 in one case by 18% plus higher overall mortality. 19:39 But again context is everything. 19:41 These studies were done specifically in heavy smokers and asbestos workers. 19:46 People already at high risk for lung cancer and the beta-carotene used was it was a synthetic. 19:52 It was a synthetic version used at very high doses. 19:55 So that's quite different from the mix of natural carotenoids you'd get from food or what's typically used in carots blends in supplements today. 20:04 Before we see beta caroten causes cancer, it's worth asking which beta-carotene at what dose and in whom. 20:10 Putting all this together, a record-breaking number of retractions, A two-decade Alzheimer's research scandal involving doctored images, 20:20 A pandemic-era fraud case that influenced the World Health Organization policy within weeks. 20:26 Well-documented financial bias running through pharmaceutical-funded research.
Vitamin E, Beta-Carotene, and Misleading Supplement Headlines 20:31 And also a deep dive into antidepressant data that only became clear once researchers went straight to the FDA data. 20:39 A landmark genome paper that buried its most newsworthy numbers in a 173-page supplemental. 20:47 a major finding in terms of genetics and uniqueness of human DNA. 20:52 And how about a pair of vitamin trials whose scary headlines about vitamin E and beta carotene left out the crucial details about the formulation's dose 21:00 and who's actually being studied. 21:04 It's not hard to see why public trust has eroded. 21:07 But here's what I want to leave you, because don't think the answer is just to throw your hands up and reject science altogether. 21:13 Science is actually a methodology, but the information that's given out to people comes from scientists and from journals. 21:21 So the same systems that allow this fraud to happen are also the systems, that caught it in many cases. 21:27 Whistleblowers, image forensic experts, independent researchers, auditing the data, and investigative journalists that outlooks at different outlets. 21:36 and groups like Retraction Watch. 21:38 So there are ways to self-correct this process, but let's face it, it is messy and it's quite tangled up. 21:45 What do we do? 21:46 We need to be critical readers. 21:48 Look at who funded the study, look at whether it's been replicated by independent groups. 21:53 When you see a scary supplement headline, ask what the formula of supplement being used was, what was the dose, and what population the studies actually 22:02 was used with, as we saw with the vitamin E and beta carotene studies.
How to Read Science Critically and Final Takeaways 22:06 Those details can completely change what a finding means for you. 22:10 Be especially cautious of single studies that get huge media coverage right away, especially during a crisis. 22:16 And don't assume that because something appears in a famous journal, it's automatically beyond question. 22:22 Some of the most damaging cases in this video happened in the prestigious journals in Subscribe for more content like this and let me know in the comments 22:36 which of these topics you'd like me to go deeper on. 22:39 I've got many videos on different topics within medicine, nutrition, and integrative medicine. 22:43 And I look forward to sharing another one with you in near future. 22:48 Thanks for listening to Health Breakthroughs with Dr. 22:50 Stengler. 22:51 If today's episode resonated with you, please follow the show, share with someone who needs it, and leave a review. 22:57 It helps more people find us. 22:59 For more resources and wellness support, visit DrStenglar.com.
Comments